From 27 September until 1 October HOYA Vision Care invited a selection of its best lens experts and VIP customers from all over the world to join its Global PAL Summit in La Toja, Spain. Goal was to discuss in depth new technological developments and s…
Author: The Medical News
FDA grants ACT clearance for Phase I/II clinical trial of hESC derived retinal cells in patients with SMD
Advanced Cell Technology, Inc. announced today that the US Food and Drug Administration (FDA) has cleared the Company’s Investigational New Drug (IND) application to immediately initiate a Phase I/II multicenter clinical trial using retinal cells deriv…
Phase 3 study of VEGF Trap-Eye regimen meets primary endpoint in patients with wet AMD
Regeneron Pharmaceuticals, Inc. and Bayer HealthCare today announced that in two parallel Phase 3 studies in patients with the neovascular form of age-related macular degeneration (wet AMD), all regimens of VEGF Trap-Eye (aflibercept ophthalmic solutio…
OptiMedica’s Catalys Precision Laser System improves precision in cataract surgery
Global ophthalmic device company OptiMedica Corp. has announced that results from a clinical study of its Catalys Precision Laser System were published in the peer-reviewed journal Science Translational Medicine.
Sun Pharma receives FDA approval for generic Tiazac ANDA
Sun Pharmaceutical Industries Ltd. announced that USFDA has granted its subsidiary an approval for its Abbreviated New Drug Application (ANDA) to market a generic version of once-a-day Tiazac® extended release capsules.
FDA approves Sun Pharma’s generic Clarinex ANDA
Sun Pharmaceutical Industries Ltd. announced that USFDA has granted it an approval for its Abbreviated New Drug Application (ANDA) to market a generic version of Schering Plough’s Clarinex® tablets, 5 mg.
Krieger Eye Institute at Sinai Hospital opens new center for treatment of retinal diseases
The Krieger Eye Institute at Sinai Hospital opened a new center for the treatment of retinal diseases in November. The retina is the layer of tissue at the back of the eye that converts images to electrical impulses. These electrical signals are then p…
Popular Science names VisionCare’s Implantable Miniature Telescope for AMD ‘Best of What’s New’ 2010
VisionCare Ophthalmic Technologies, Inc., a developer of advanced visual prosthetic devices, today announced the Implantable Miniature Telescope (by Dr. Isaac Lipshitz), designed to improve vision in patients with end-stage age-related macular degeneration (AMD) is named “Best of What’s New” 2010…
Study reveals true effects of malaria on African generations
Almost a third of cerebral malaria survivors developed epilepsy or other behavioral disorders in the most comprehensive study to date of the disease in African children, solidifying the link between malaria and neuropsychiatric disorders that affect hu…
Freedom Meditech announces clinical study results of I-SugarX non-invasive glucose monitoring system
Freedom Meditech, Inc., the developer of non-invasive, ophthalmic-based products to detect and manage diabetes, today announced results of a clinical study that showed a high correlation between low to high blood glucose levels and non-invasive glucose…
Tobii launches TX300 Eye Tracker for linguistics and behavioral research
Tobii Technology, the global market leader in eye tracking, announced today its new Tobii TX300™ Eye Tracker. The TX300 is the first higher-frequency eye-tracking hardware that allows research subjects the freedom of head movement, which helps scient…
Study shows dogs attack children’s face, eyes
As dog bites become an increasingly major public health concern, a new study shows that unsupervised children are most at risk for bites, that the culprits are usually family pets and if they bite once, they will bite again with the second attack often…
Researchers study drug’s ability to restore retinal health in eyes of diabetic patients
One drug’s startling ability to restore retinal health in the eyes of diabetic mice has researchers wanting to learn more about how it works and whether it might do the same for people.
Researchers identify gene linked to melanoma metastasis
Researchers at Washington University School of Medicine in St. Louis have identified a gene linked to the spread of eye melanoma.
Retina Implant’s microchip restores useful vision in patients blind due to retinitis pigmentosa
Retina Implant AG, a leading developer of subretinal implants for the visually impaired, today announced the publication of a peer-reviewed study in Proceedings of the Royal Society B discussing the technical and clinical results obtained during their …
STAAR Surgical third quarter total net sales increases 6% to $13.2 million
STAAR Surgical Company, a leading developer, manufacturer and marketer of minimally invasive ophthalmic products, today reported results for the third quarter ended October 1, 2010. Revenue for the period grew 6% to $13.2 million reflecting core produ…
RegeneRx announces positive results from RGN-259 non-clinical study for Dry Eye Syndrome
RegeneRx Biopharmaceuticals, Inc. today announced the results of its first non-clinical dry eye study using RGN-259, RegeneRx’s ophthalmic, preservative-free eye drop for the treatment of Dry Eye Syndrome (DES). In the study, animals were treated with …
Allergan third quarter diluted loss per share increases to $2.21
Allergan, Inc. today announced operating results for the quarter ended September 30, 2010. Allergan also announced that its Board of Directors has declared a third quarter dividend of $0.05 per share, payable on December 1, 2010 to stockholders of reco…
Catalyst’s CPP-115 improves retinal safety profile than vigabatrin
Catalyst Pharmaceutical Partners, Inc. today announced positive results from a series of CPP-115 preclinical safety and efficacy evaluations. CPP-115 was found to have a significantly improved retinal safety profile compared to vigabatrin.
Diabetes threatens the eyesight of many unsuspecting Americans
Diabetes causes more new cases of legal blindness among working-age Americans than any other disease. If diabetics are monitored regularly by their ophthalmologist, this vision loss is almost always avoidable. Yet, tragically, more than half of all peo…